Welcome to LookChem.com Sign In|Join Free
  • or
(3-fluoro-2-nitro-phenyl)-(3-fluoro-phenyl)-amine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

500302-19-2

Post Buying Request

500302-19-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

500302-19-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 500302-19-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,0,0,3,0 and 2 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 500302-19:
(8*5)+(7*0)+(6*0)+(5*3)+(4*0)+(3*2)+(2*1)+(1*9)=72
72 % 10 = 2
So 500302-19-2 is a valid CAS Registry Number.

500302-19-2Relevant academic research and scientific papers

ARYL SULFAMIDE DERIVATIVES AND METHODS OF THEIR USE

-

Page/Page column 132, (2008/12/06)

The present invention is directed to aryl sulfamide derivatives of formula (I): or a pharmaceutically acceptable salt, stereoisomer or tautomer thereof, which are monoamine reuptake inhibitors, compositions containing these derivatives, and methods of their use for the prevention and treatment of conditions, including, inter alia, vasomotor symptoms, sexual dysfunction, gastrointestinal disorders and genitourinary disorder, depression disorders, endogenous behavioral disorders, cognitive disorders, diabetic neuropathy, pain, and other diseases or disorders.

Phenylaminopropanol derivatives and methods of their use

-

Page/Page column 87, (2010/11/26)

The present invention is directed to phenylaminopropanol derivatives of formulae I, II, and III: [image] or a pharmaceutically acceptable salt thereof, compositions containing these derivatives, and methods of their use for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromyalgia syndrome, nervous system disorders, and combinations thereof, particularly those conditions selected from the group consisting of major depressive disorder, vasomotor symptoms, stress and urge urinary incontinence, fibromyalgia, pain, diabetic neuropathy, schizophrenia, and combinations thereof.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 500302-19-2